ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure

ZnO nanoparticles (ZnONPs) have been shown to have therapeutic potential in some diseases such as diabetes and cancer. However, concentration-dependent adverse effects have also been reported. Studies which evaluate the effects of ZnONPs on the cardiovascular system are scarce. This study aimed to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceballos-Gutiérrez, Adriana, Rodríguez-Hernández, Alejandrina, Álvarez-Valadez, María del Rosario, Limón-Miranda, Saraí, Andrade, Felipa, Figueroa-Gutiérrez, Alejandro, Díaz-Reval, Irene, Apolinar-Iribe, Alejandro, Castro-Sánchez, Luis, Alamilla, Javier, Sánchez-Pastor, Enrique, Virgen-Ortiz, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472382/
https://www.ncbi.nlm.nih.gov/pubmed/34578635
http://dx.doi.org/10.3390/nano11092319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472382/
https://www.ncbi.nlm.nih.gov/pubmed/34578635
http://dx.doi.org/10.3390/nano11092319

Ejemplares similares